rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Margaret Dugan

Chief Medical Officer

Company insider

Files Form 4 as: Chief Medical Officer, Whitehawk Therapeutics; Director, BeOne Medicines; Chief Medical Officer, Schrodinger.

Every Form 4 they filed

In numbers

Trades disclosed
34
Buys
0
Sells
3
Bought
$0
Sold
$188K
Companies
3
Companies where not an officer
1
First trade
28 Feb 2022
Last trade
15 Sep 2026
Last filed
18 Sep 2026

Companies traded

Where they are an officer
WHWK Whitehawk TherapeuticsOfficer · Biotechnology · last 15 Sep 20260 buys · 0 sells
SDGR SchrodingerOfficer · Life-science tools · last 16 Oct 20250 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ONC BeOne MedicinesDirector · Biotechnology · last 11 Jun 20260 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—81,250 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—18,980 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—18,980 at $0.00filing
22 May 2026filed 27 May 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$66K212 at $309.60filing
22 May 2026filed 27 May 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$66K212 at $309.60filing
14 May 2026filed 18 May 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Code A$75K19,132 at $3.92filing
14 May 2026filed 18 May 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Code A$75K19,132 at $3.92filing
1 Apr 2026filed 3 Apr 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—283,157 at $0.00filing
1 Apr 2026filed 3 Apr 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—283,157 at $0.00filing
1 Dec 2025filed 2 Dec 2025WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—650,000 at $0.00filing
1 Dec 2025filed 2 Dec 2025WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—55,309 at $0.00filing
16 Oct 2025filed 17 Oct 2025SDGR SchrodingerLife-science toolsSEC FORM 4 Sold$29K1,395 at $21.07filing
21 May 2025filed 22 May 2025ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code A—22,750 at $0.00filing

News

Contrasting PainReform (NASDAQ:PRFX) & BeOne Medicines (NASDAQ:ONC)ONC · tickerreport.com · 21 Oct 2026BeOne Medicines (NASDAQ:ONC) Price Target Raised to $420.00ONC · tickerreport.com · 10 Oct 2026

0 headlines in the last 90 days name Margaret Dugan; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Karen AkinsanyaOfficer · Officer at Schrodinger, filing Form 4 there in the last year
David James LennonChief Executive Officer · Chief Executive Officer at Whitehawk Therapeutics, filing Form 4 there in the last year
David DornanChief Scientific Officer · Chief Scientific Officer at Whitehawk Therapeutics, filing Form 4 there in the last year
Bryan BallOfficer · Insider at Whitehawk Therapeutics, filing Form 4 there in the last year
Scott M. GiacobelloChief Financial Officer · Chief Financial Officer at Whitehawk Therapeutics, filing Form 4 there in the last year
Xiaodong WangDirector and Other role · Also traded ONC in the last 90 days
Chan Henry LeeSVP, General Counsel · Also traded ONC in the last 90 days
Titus B. BallPrincipal Accounting Officer · Also traded ONC in the last 90 days